Return-to-Play Post-Myocarditis Safety Calculator
- Return-to-Play Post-Myocarditis: Explanation and Clinical Context
This calculator applies current expert consensus for evaluating return-to-play (RTP) readiness after myocarditis. Clearance requires a minimum restriction period of 3–6 months, complete symptom resolution, normalized cardiac biomarkers (troponin, CRP), recovery of ventricular function (LVEF ≥ 50%), and absence of ventricular arrhythmias on resting or exercise ECG. CMR should demonstrate resolution of active inflammation; residual LGE may be acceptable with shared decision-making and close follow-up.
The logic follows major recommendations from the American College of Cardiology (ACC), American Heart Association (AHA), and European Society of Cardiology (ESC), not a numeric risk score. Output categories: Not Cleared, Conditional Clearance (residual LGE, no arrhythmia), and Cleared for Graded RTP (meets all criteria). Final decisions require clinical judgment, sport-specific risk assessment, and athlete preference.
References:
Yamagata K, et al. Return-to-Play Post-Myocarditis for Athletes. Curr Treat Options Cardio Med. 2024.
Gluckman TJ, et al. ACC Expert Consensus Decision Pathway on Myocarditis and RTP. JACC 2024/2025.
Pelliccia A, et al. 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease.
Zipes DP, et al. AHA/ACC Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities. Circulation. 2015.
Discussion
No discussions yet. Be the first to comment.
Create Note
Notes are stored privately on your device only. No login required. Nothing is uploaded or shared.